• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞小窝蛋白-1的表达促成肺部炎症和损伤的机制。

Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury.

作者信息

Hu Guochang, Ye Richard D, Dinauer Mary C, Malik Asrar B, Minshall Richard D

机构信息

Department of Pharmacology, University of Illinois College of Medicine, 835 South Wolcott Ave., Chicago, IL 60612, USA.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294(2):L178-86. doi: 10.1152/ajplung.00263.2007. Epub 2007 Nov 9.

DOI:10.1152/ajplung.00263.2007
PMID:17993589
Abstract

Caveolin-1 present in immune cells may be involved in regulation of the inflammatory response. Here, using caveolin-1-null (Cav-1(-/-)) mice, we addressed the role of caveolin-1 in polymorphonuclear neutrophils (PMNs) in regulating PMN activation-mediated lung injury. In lungs of wild-type (Cav-1(+/+)) mice perfused at constant flow with Krebs-Henseleit solution, addition of Cav-1(+/+) PMNs (4 x 10(6) cells) into the perfusate followed by their activation with formyl-Met-Leu-Phe (fMLP, 1.0 muM) plus platelet-activating factor (1.0 nM) increased pulmonary microvessel filtration coefficient by 150% and wet-to-dry lung weight ratio by 50% as well as PMN accumulation in lungs. These responses were markedly reduced in lungs perfused with Cav-1(-/-) PMNs followed by addition of the same activating agents. fMLP-stimulated adhesion of Cav-1(-/-) PMNs to pulmonary microvascular endothelial cells and migration of Cav-1(-/-) PMNs across endothelial monolayers were also impaired compared with Cav-1(+/+) PMNs. Cav-1(-/-) PMNs showed 50-80% reduction in PMA- or fMLP-stimulated superoxide production compared with Cav-1(+/+) PMNs. In addition, Cav-1(-/-) PMNs had decreased migratory activity (50%) and adhesion to fibrinogen (40%) in response to fMLP. Rac1 and Rac2 were activated in Cav-1(+/+) PMNs after stimulation of fMLP but not in Cav-1(-/-) PMNs. Exogenous expression of caveolin-1 in COS-phox cells augmented the fMLP-induced Rac1 activation and superoxide production, indicating a direct role of caveolin-1 in the mechanism of superoxide production. Thus caveolin-1 expression in PMNs plays a key role in mediating PMN activation, adhesion, and transendothelial migration and in PMN activation-induced lung inflammation and vascular injury.

摘要

免疫细胞中存在的小窝蛋白-1可能参与炎症反应的调节。在此,我们使用小窝蛋白-1基因敲除(Cav-1(-/-))小鼠,探讨了小窝蛋白-1在多形核中性粒细胞(PMN)中对PMN活化介导的肺损伤调节作用。在以恒定流量用Krebs-Henseleit溶液灌注的野生型(Cav-1(+/+))小鼠肺中,向灌注液中加入Cav-1(+/+) PMN(4×10⁶个细胞),随后用甲酰甲硫氨酸-亮氨酸-苯丙氨酸(fMLP,1.0 μM)加血小板活化因子(1.0 nM)激活,可使肺微血管滤过系数增加150%,肺湿重与干重之比增加50%,同时肺内PMN积聚增加。在用Cav-1(-/-) PMN灌注并加入相同激活剂后,这些反应明显减弱。与Cav-1(+/+) PMN相比,fMLP刺激的Cav-1(-/-) PMN与肺微血管内皮细胞的黏附以及Cav-1(-/-) PMN跨内皮单层的迁移也受损。与Cav-1(+/+) PMN相比,Cav-1(-/-) PMN在佛波酯(PMA)或fMLP刺激下超氧化物生成减少50 - 80%。此外,Cav-(-/-) PMN对fMLP的迁移活性降低(50%),对纤维蛋白原的黏附减少(40%)。fMLP刺激后,Cav-1(+/+) PMN中的Rac1和Rac2被激活,而Cav-1(-/-) PMN中未被激活。在COS-phox细胞中外源表达小窝蛋白-1可增强fMLP诱导的Rac1激活和超氧化物生成,表明小窝蛋白-1在超氧化物生成机制中起直接作用。因此,PMN中小窝蛋白-1的表达在介导PMN活化、黏附、跨内皮迁移以及PMN活化诱导的肺部炎症和血管损伤中起关键作用。

相似文献

1
Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury.中性粒细胞小窝蛋白-1的表达促成肺部炎症和损伤的机制。
Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294(2):L178-86. doi: 10.1152/ajplung.00263.2007. Epub 2007 Nov 9.
2
Chemoattractant-stimulated Rac activation in wild-type and Rac2-deficient murine neutrophils: preferential activation of Rac2 and Rac2 gene dosage effect on neutrophil functions.趋化因子刺激下野生型和Rac2缺陷型小鼠中性粒细胞中的Rac激活:Rac2的优先激活及Rac2基因剂量对中性粒细胞功能的影响
J Immunol. 2002 Nov 1;169(9):5043-51. doi: 10.4049/jimmunol.169.9.5043.
3
Role of caveolin-1 in regulation of inflammation: different strokes for different folks.小窝蛋白-1在炎症调节中的作用:因人而异。
Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294(2):L175-7. doi: 10.1152/ajplung.00488.2007. Epub 2007 Nov 30.
4
Impaired NADPH oxidase activity in Rac2-deficient murine neutrophils does not result from defective translocation of p47phox and p67phox and can be rescued by exogenous arachidonic acid.Rac2缺陷型小鼠中性粒细胞中NADPH氧化酶活性受损并非由p47phox和p67phox的易位缺陷所致,且可通过外源性花生四烯酸挽救。
J Leukoc Biol. 2006 Jan;79(1):223-34. doi: 10.1189/jlb.0705371. Epub 2005 Nov 7.
5
Reconstitution of chemotactic peptide-induced nicotinamide adenine dinucleotide phosphate (reduced) oxidase activation in transgenic COS-phox cells.趋化肽诱导的烟酰胺腺嘌呤二核苷酸磷酸(还原型)氧化酶在转基因COS-phox细胞中的重构激活。
J Immunol. 2004 Dec 15;173(12):7462-70. doi: 10.4049/jimmunol.173.12.7462.
6
Mechanisms of increased pulmonary microvascular permeability induced by FMLP in isolated rabbit lungs.在离体兔肺中,FMLP诱导肺微血管通透性增加的机制。
J Appl Physiol (1985). 1992 Nov;73(5):2074-82. doi: 10.1152/jappl.1992.73.5.2074.
7
Intercellular adhesion molecule-1-dependent neutrophil adhesion to endothelial cells induces caveolae-mediated pulmonary vascular hyperpermeability.细胞间黏附分子 -1 依赖的中性粒细胞与内皮细胞的黏附诱导小窝介导的肺血管通透性增加。
Circ Res. 2008 Jun 20;102(12):e120-31. doi: 10.1161/CIRCRESAHA.107.167486. Epub 2008 May 29.
8
Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide.小窝蛋白-1调节核因子-κB的激活以及肺部对脂多糖诱导的脓毒症的炎症反应。
J Immunol. 2006 Oct 1;177(7):4853-60. doi: 10.4049/jimmunol.177.7.4853.
9
Rac GTPase isoform-specific regulation of NADPH oxidase and chemotaxis in murine neutrophils in vivo. Role of the C-terminal polybasic domain.Rac GTP酶同工型对体内小鼠中性粒细胞中NADPH氧化酶和趋化性的特异性调节。C末端多碱性结构域的作用。
J Biol Chem. 2005 Jan 14;280(2):953-64. doi: 10.1074/jbc.M408820200. Epub 2004 Oct 25.
10
Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP.溶血磷脂酰胆碱通过升高环磷酸腺苷来调节中性粒细胞氧化剂的产生。
J Immunol. 2005 Mar 1;174(5):2981-9. doi: 10.4049/jimmunol.174.5.2981.

引用本文的文献

1
Revolutionizing Autoimmune Research: The Role of Caveolin-1.革新自身免疫研究:小窝蛋白-1的作用
Immun Inflamm Dis. 2025 Aug;13(8):e70230. doi: 10.1002/iid3.70230.
2
The critical roles of caveolin-1 in lung diseases.小窝蛋白-1在肺部疾病中的关键作用。
Front Pharmacol. 2024 Sep 24;15:1417834. doi: 10.3389/fphar.2024.1417834. eCollection 2024.
3
The Regulation of Neutrophil Migration in Patients with Sepsis: The Complexity of the Molecular Mechanisms and Their Modulation in Sepsis and the Heterogeneity of Sepsis Patients.
中性粒细胞在脓毒症患者中的迁移调控:脓毒症中分子机制的复杂性及其调控以及脓毒症患者的异质性。
Cells. 2023 Mar 24;12(7):1003. doi: 10.3390/cells12071003.
4
Role of Caveolin-1 in Sepsis - A Mini-Review.Caveolin-1 在脓毒症中的作用——综述。
Front Immunol. 2022 Jul 15;13:902907. doi: 10.3389/fimmu.2022.902907. eCollection 2022.
5
Experimental Models to Study the Pathogenesis of Malaria-Associated Acute Respiratory Distress Syndrome.疟疾相关急性呼吸窘迫综合征发病机制的实验模型。
Front Cell Infect Microbiol. 2022 May 23;12:899581. doi: 10.3389/fcimb.2022.899581. eCollection 2022.
6
Distinct transcription factor networks control neutrophil-driven inflammation.不同的转录因子网络控制中性粒细胞驱动的炎症。
Nat Immunol. 2021 Sep;22(9):1093-1106. doi: 10.1038/s41590-021-00968-4. Epub 2021 Jul 19.
7
YAP expression in endothelial cells prevents ventilator-induced lung injury.YAP 在血管内皮细胞中的表达可预防呼吸机所致肺损伤。
Am J Physiol Lung Cell Mol Physiol. 2021 Apr 1;320(4):L568-L582. doi: 10.1152/ajplung.00472.2020. Epub 2021 Feb 10.
8
Study of immune responses in mice to oral administration of Flor·Essence.小鼠对口服Flor·Essence的免疫反应研究。
Mol Clin Oncol. 2020 Jun;12(6):533-540. doi: 10.3892/mco.2020.2023. Epub 2020 Mar 30.
9
Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis.Klotho 通过抑制肺成纤维细胞的激活、迁移和细胞外基质的产生来拮抗肺纤维化:对特发性肺纤维化的治疗意义。
Aging (Albany NY). 2020 Apr 3;12(7):5812-5831. doi: 10.18632/aging.102978.
10
Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells.窖蛋白-1 调控结核分枝杆菌感染的小鼠单核细胞来源的髓系抑制细胞中囊泡 TLR2 的表达、p38 信号通路和 T 细胞抑制作用。
Front Immunol. 2019 Dec 3;10:2826. doi: 10.3389/fimmu.2019.02826. eCollection 2019.